Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Potent murine CCR2 receptor antagonist presented at World Congress on Inflammation

July 1, 1999

Gene sequences related to X-linked inhibitor of apoptosis protein discovered

July 1, 1999

Lundbeck develops radiolabeled 5-HT2 receptor antagonist for PET studies

June 30, 1999

ICAgen licenses novel ion channel genes from SUNY

June 30, 1999

CyDex and Peptichemio sign licensing agreement for drug delivery technology

June 28, 1999

Neurogen licenses drug discovery technology to Pfizer

June 28, 1999

German pharmaceutical giant teams up with national biotech upstart in life science research

June 25, 1999

Pharsight's KADD expected to accelerate clinical drug development at AstraZeneca

June 25, 1999

AxyS Pharmaceuticals enters combinatorial chemistry collaboration with Novalon

June 25, 1999

MiniMed enters collaboration with Elan for Medipad drug delivery system

June 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...